Maria Helena Jacob
Overview
Explore the profile of Maria Helena Jacob including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
151
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Petkovic J, Welch V, Jacob M, Yoganathan M, Ayala A, Cunningham H, et al.
Implement Sci
. 2016 Dec;
11(1):162.
PMID: 27938409
Background: Systematic reviews are important for decision makers. They offer many potential benefits but are often written in technical language, are too long, and do not contain contextual details which...
2.
Barrier M, Meloche J, Jacob M, Courboulin A, Provencher S, Bonnet S
Cell Mol Life Sci
. 2012 Mar;
69(17):2805-31.
PMID: 22446747
The pathobiology of pulmonary arterial hypertension (PAH) involves a remodeling process in distal pulmonary arteries, as well as vasoconstriction and in situ thrombosis, leading to an increase in pulmonary vascular...
3.
Courboulin A, Tremblay V, Barrier M, Meloche J, Jacob M, Chapolard M, et al.
Respir Res
. 2011 Sep;
12:128.
PMID: 21951574
Background: Pulmonary arterial hypertension (PAH) is a vascular remodeling disease characterized by enhanced proliferation of pulmonary artery smooth muscle cell (PASMC) and suppressed apoptosis. This phenotype has been associated with...
4.
Paulin R, Meloche J, Jacob M, Bisserier M, Courboulin A, Bonnet S
Am J Physiol Heart Circ Physiol
. 2011 Sep;
301(5):H1798-809.
PMID: 21890685
Pulmonary arterial hypertension (PAH) is an obstructive vasculopathy characterized by enhanced pulmonary artery smooth muscle cell (PASMC) proliferation and suppressed apoptosis. This phenotype is sustained by the activation of the...